Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 5 institutions in 2 countries.
Altaf A KondkarDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.ORCID 0000-0002-5516-6951
Taif A AzadDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
Tahira SultanDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
Tanvir KhatlaniDepartment of Blood and Cancer Research, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University of Health Sciences, Ministry of National Guard Health Affairs, Riyadh 11426, Saudi Arabia.
Abdulaziz A AlshehriDepartment of Ophthalmology, Imam Abdulrahman Alfaisal Hospital, Riyadh 14723, Saudi Arabia.
Rakesh RadhakrishnanDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55347, USA.
Glenn P LoboDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55347, USA.
Ehab AlsirhyDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.ORCID 0000-0003-4343-8056
Faisal A AlmobarakDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.ORCID 0000-0003-3504-2828
Essam A OsmanDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
Saleh A Al-ObeidanDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.ORCID 0000-0002-0573-4017
King Saud University · SAUniversity of Minnesota · USImam Abdulrahman Al Faisal Hospital · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Saud Medical City · SA
Funding
King Saud University through the Vice Deanship of Scientific Research Chair and Glaucoma Research Chair in Ophthalmology GRC-2024
6 · The paper itself
Abstract
This study investigated the association between apolipoprotein E (
Indexed as
Apolipoprotein E2Genetic Predisposition to DiseaseGlaucoma, Angle-ClosurePolymorphism, Single NucleotideAllelesCase-Control StudiesFemaleGene FrequencyGenotypeHaplotypesHeterozygoteHumansMaleRisk FactorsSaudi ArabiaApolipoprotein E2angle-closureapolipoprotein Egeneticsglaucomapolymorphismspseudoexfoliationrs429358rs7412Saudi
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.